Rosiglitazone, may be a good choice for patients with type 2-diabetes who require additional medications to prevent heart attacks.
Read More »Issue 164 Item 15 Obesity Increases Risk for Death from Cancer
Researchers conclude that as many as 14% of cancer deaths in men and 20% of cancer deaths in women may be attributable to excess weight.
Read More »Issue 163 Item 1 ‘Impaired Glucose Tolerance Tied to Increased Risk of Cancer Mo
Hyperinsulinemia may promote cancer development, since insulin has been shown to stimulate cell growth, especially colonic epithelial cells.
Read More »Issue 163 Item 2 Diabetes Drugs Inappropriately Prescribed
Despite explicit warnings on package inserts, metformin and thiazolidinediones are often given to diabetics hospitalized with heart failure.
Read More »Issue 163 Item 3 Low-Glycemic-Index Mexican Diet Helpful in Obese Type 2 Diabeti
A low-glycemic-index (GI) Mexican diet reduces weight and improves glycemic control in obese type 2 diabetic Mexicans.
Read More »Issue 163 Item 4 Effective Treatments Available for Diagnosed Diabetic Neuropath
Without a cure, Intensive glucose control and pain management are the most effective treatments for slowing disease progression and improving quality of life.
Read More »Issue 163 Item 5 Regular Walking Decreases Morbidity Rates by 50% in Diabetics
Walking just 30-45 minutes a day reduces Mortality by 50%!
Read More »Issue 163 Item 6 Statins Cost-Effective for Diabetics With Mildly Elevated LDL
A cost saving of 7.4 Billion dollars could be obtained if statin therapy is used for ype-2 diabetes and mildly elevated (100-129 mg/dL) LDL cholesterol, but no clinical evidence cardiovascular disease, researchers report in the June issue of Diabetes Care.
Read More »Issue 163 Item 7 Poor Understanding of Disease Management Leads to Non-complianc
Non-compliance from patients with type 2 diabetes may be related to poor understanding of management guidelines.
Read More »Long-term ACE Inhibitor Treatment Promotes Renal Health and Imp
Long-term therapy with an angiotensin-converting enzyme (ACE) inhibitor appears to reduce urinary albumin excretion and improve lipid metabolism in patients with hypertension, research findings suggest.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.